Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Prothena Corporation plc (PRTA)

37.01   -2.52 (-6.37%) 01-19 08:18
Open: 38.25 Pre. Close: 39.53
High: 39.415 Low: 36.85
Volume: 579,752 Market Cap: 1,724M
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing PRX002/RG7935 that is in Phase 2 clinical trial for treating Parkinson's disease and other related synucleinopathies; and PRX004, an antibody that is in Phase 1 clinical trial for the treatment of ATTR amyloidosis. Its discovery-stage programs include Tau for treating Alzheimer's disease, frontotemporal dementia, progressive supranuclear palsy, chronic traumatic encephalopathy, and other tauopathies; AÃ?, or Amyloid Beta, a protein for the treatment of Alzheimer's disease; TDP-43 for amyotrophic lateral sclerosis and frontotemporal dementia; and other products for neurodegenerative diseases. The company has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein; and a collaboration agreement with Bristol-Myers Squibb to develop antibodies. Prothena Corporation plc was founded in 2012 and is based in Dublin, Ireland.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 39.47 - 39.662 39.662 - 39.851
Low: 36.308 - 36.539 36.539 - 36.766
Close: 36.583 - 36.949 36.949 - 37.309

Technical analysis

as of: 2022-01-18 4:33:43 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 51.76     One year: 58.46
Support: Support1: 35.04    Support2: 29.15
Resistance: Resistance1: 44.32    Resistance2: 50.06
Pivot: 43.37
Moving Average: MA(5): 38.67     MA(20): 44.34
MA(100): 58.18     MA(250): 43.86
MACD: MACD(12,26): -2.91     Signal(9): -2.26
Stochastic oscillator: %K(14,3): 19.23     %D(3): 18.91
RSI: RSI(14): 33.68
52-week: High: 79.75  Low: 10.72  Change(%): 171.9
Average Vol(K): 3-Month: 41398  10-Days: 57729

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
PRTA has closed above bottom band by 11.6%. Bollinger Bands are 39% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 14 Jan 2022
Is Prothena Corporation PLC (PRTA) a Leader in the Healthcare Sector? - InvestorsObserver

Wed, 12 Jan 2022
Cramer's Mad Money Recap 1/12: Tesla, Ford, GM - TheStreet

Thu, 23 Dec 2021
5 Biotech Stocks That More Than Doubled This Year - Nasdaq

Wed, 01 Dec 2021
Prothena: A Biotech Company With A Promising Pipeline - Seeking Alpha

Thu, 04 Nov 2021
Prothena Reports Third Quarter 2021 Financial Results and Business Highlights - Yahoo Finance

Fri, 01 Oct 2021
Prothena Announces Executive Appointments - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Outperform Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 47
Shares Float (M) 25
% Held by Insiders 0.05
% Held by Institutions 90.17
Shares Short (K) 2,470
Shares Short P. Month (K) 1,900

Stock Financials

EPS 1.530
EPS Est This Year -4.410
EPS Est Next Year -5.360
Book Value (p.s.) 10.540
Profit Margin 34.76
Operating Margin 37.42
Return on Assets (ttm) 9.4
Return on Equity (ttm) 19.8
Qtrly Rev. Growth 88545.9
Gross Profit (p.s.) -1.589
Sales Per Share 4.288
EBITDA (p.s.) 1.631
Qtrly Earnings Growth
Operating Cash Flow (M) 96
Levered Free Cash Flow (M) 82

Stock Valuations

PE Ratio 24.19
PEG Ratio
Price to Book value 3.51
Price to Sales 8.63
Price to Cash Flow 17.97

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.